Alzheon News2018-02-06T08:27:25+00:00

Press Releases

23Jul, 2018

Alzheon Presents New Findings in APOE4/4 Homozygous Patients with Mild Alzheimer’s Disease, Further Supporting Precision Medicine Approach and Planned Confirmatory Clinical Trial with ALZ-801

July 23rd, 2018|

Presentation at the Alzheimer’s Association International Conference Details Patient Responder Analyses on Key Clinical Outcomes FRAMINGHAM, Mass., July 23, 2018 – Alzheon, Inc., a clinical-stage biopharmaceutical company focused [...]

Load More